Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Clinical trial NCT07044336 · RECRUITING

Trial details

NCT number: NCT07044336
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Endometrial Cancer Malignant Solid Tumour

Start date: 2025-08-01
Primary completion: 2027-10-15
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.